CVS, Cigna, and UnitedHealth Challenge FTC’s Insulin Price Manipulation Claims in Major Legal Dispute

Leading healthcare companies CVS Health, Cigna, and UnitedHealth Group have taken legal action against the Federal Trade Commission (FTC), contesting an administrative process spearheaded by Chair Lina Khan. The complaint, initiated by the FTC in September, accuses the companies’ pharmacy benefit manager (PBM) subsidiaries of manipulating insulin prices through practices likened to “bribes.” The healthcare giants argue that the FTC’s proceedings infringe upon their constitutional rights. More details on this legal conflict can be found in the original article.